0.7913  0.021 (2.77%)		06-16 16:00
Open: 0.83 High: 0.8235 Volume: 43,584		Pre. Close: 0.77 Low: 0.79 Market Cap: 43(M)

Short term
Mid term
Targets	6-month :	1.06	1-year :	1.2
Resists	First :	0.91	Second :	1.02
Pivot price	0.83
Supports	First :	0.71	Second :	0.59
MAs	MA(5) :	0.8	MA(20) :	0.84
	MA(100) :	0.98	MA(250) :	1.47
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	34.5	D(3) :	44
RSI	RSI(14): 41.2
52-week	High :	2.65	Low :	0.68

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ MODD ] has closed above bottom band by 20.5%. Bollinger Bands are 51.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	0.83 - 0.83	0.83 - 0.84
Low:	0.78 - 0.78	0.78 - 0.79
Close:	0.78 - 0.79	0.79 - 0.8

Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.

Mon, 16 Jun 2025
Modular Medical to Present Data from Study Examining Pump Delivery of a GLP-1R Agonist at the ADA 85th Scientific Sessions | MODD Stock News - GuruFocus

Mon, 16 Jun 2025
Modular Medical to Present Data from Study Examining Pump Delivery of a GLP-1R Agonist at the ADA 85th Scientific Sessions - ACCESS Newswire

Mon, 16 Jun 2025
Revolutionary GLP-1 Pump Delivery Study: Modular Medical Takes On Ozempic Side Effects at ADA Conference - Stock Titan

Wed, 28 May 2025
Modular Medical Appoints Jeff Goldberg to Board - TipRanks

Tue, 27 May 2025
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event Titled "Making Di - PharmiWeb.com

Tue, 27 May 2025
Revolutionary Diabetes Tech: Modular Medical CEO to Reveal New FDA-Cleared Insulin Pump Targeting 1.9M Patients - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	54 (M)
Shares Float	32 (M)
Held by Insiders	6.7 (%)
Held by Institutions	39.3 (%)
Shares Short	137 (K)
Shares Short P.Month	212 (K)

EPS	-0.53
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.25
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	-125.3 %
Return on Equity (ttm)	-257.8 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	-0.33
Qtrly Earnings Growth	0 %
Operating Cash Flow	-15 (M)
Levered Free Cash Flow	-10 (M)

PE Ratio	-1.5
PEG Ratio	0
Price to Book value	3.16
Price to Sales	0
Price to Cash Flow	-2.88

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.